AE	Adverse Event
aHR	Adjusted Hazard Ratio
ATC	Anatomical Therapeutic Chemical
BDI-II	Beck Depression Inventory-II
BMI	Body Mass Index
C-SSRS	Columbia-Suicide Severity Rating Scale
CI	Confidence Interval
CNS	Central Nervous System
EHR	Electronic Health Record
EMA	European Medicines Agency
FDA	U.S. Food and Drug Administration
GAD-7	Generalized Anxiety Disorder-7
GIP	Glucose-Dependent Insulinotropic Polypeptide
GLP-1	Glucagon-Like Peptide-1
GLP-1 RA	Glucagon-Like Peptide-1 Receptor Agonist
GRADE	Grading of Recommendations Assessment, Development and Evaluation
HADS	Hospital Anxiety and Depression Scale
HADS-A	Hospital Anxiety and Depression Scale—Anxiety
HADS-D	Hospital Anxiety and Depression Scale—Depression
HR	Hazard Ratio
HRQoL	Health-Related Quality of Life
ICD	International Classification of Diseases
JBI	Joanna Briggs Institute
MCS	Mental Component Summary
MD	Mean Difference
MDD	Major Depressive Disorder
MeSH	Medical Subject Headings
NR	Not Reported
OR	Odds Ratio
PHQ-9	Patient Health Questionnaire-9
PRISMA	Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PROSPERO	International Prospective Register of Systematic Reviews
PTSD	Post-Traumatic Stress Disorder
RCT	Randomized Controlled Trial
ROBINS-I	Risk Of Bias In Non-randomized Studies of Interventions
RoB 2	Risk of Bias 2
RR	Relative Risk
SE	Standard Error
SF-36 MCS	36-Item Short Form Health Survey Mental Component Summary
SGLT2	Sodium-Glucose Cotransporter 2
SGLT2i	Sodium-Glucose Cotransporter-2 Inhibitor
SWiM	Synthesis Without Meta-analysis
T2DM	Type 2 Diabetes Mellitus